1. Farley, Sean J, Grishok, Alla, Zeldich, Ella. 2022. Shaking up the silence: consequences of HMGN1 antagonizing PRC2 in the Down syndrome brain. In Epigenetics & chromatin, 15, 39. doi:10.1186/s13072-022-00471-6. https://pubmed.ncbi.nlm.nih.gov/36463299/
2. Yang, De, Han, Zhen, Alam, Md Masud, Oppenheim, Joost J. 2018. High-mobility group nucleosome binding domain 1 (HMGN1) functions as a Th1-polarizing alarmin. In Seminars in immunology, 38, 49-53. doi:10.1016/j.smim.2018.02.012. https://pubmed.ncbi.nlm.nih.gov/29503123/
3. Li, Dang-Dang, Yang, Zhan-Qing, Guo, Chuan-Hui, Guo, Bin, Yue, Zhan-Peng. . Hmgn1 acts downstream of C/EBPβ to regulate the decidualization of uterine stromal cells in mice. In Cell cycle (Georgetown, Tex.), 14, 3461-74. doi:10.1080/15384101.2015.1093704. https://pubmed.ncbi.nlm.nih.gov/26566865/
4. Guo, Yangyang, Zhang, Rongrong, Xu, Hongjie, Mai, Yifeng, Wu, Zhixuan. 2024. Pan-cancer Multi-omics Analysis Reveals HMGN1 as a Potential Prognostic and Immune Infiltration-associated Biomarker. In Current medicinal chemistry, , . doi:10.2174/0109298673268718231122103638. https://pubmed.ncbi.nlm.nih.gov/38310387/
5. Ihewulezi, Chibuike, Saint-Jeannet, Jean-Pierre. 2021. Function of chromatin modifier Hmgn1 during neural crest and craniofacial development. In Genesis (New York, N.Y. : 2000), 59, e23447. doi:10.1002/dvg.23447. https://pubmed.ncbi.nlm.nih.gov/34478234/
6. Zhu, Nan, Hansen, Ulla. 2007. HMGN1 modulates estrogen-mediated transcriptional activation through interactions with specific DNA-binding transcription factors. In Molecular and cellular biology, 27, 8859-73. doi:. https://pubmed.ncbi.nlm.nih.gov/17938209/